B.Braun

Areas of activity

For 2017, B. Braun has four divisions:

• B. Braun Avitum (supply of medical goods and services in the field of extracorporeal blood purification),
• Hospital Care (manufacturing products for the day-to-day operation of clinical and intensive care units),
• Aesculap (specializes in surgical instrumentation and sutures) and
• Out Patient Market.

Performance indicators

As of 2015, nearly 24,000 patients are receiving dialysis therapy at 300 dialysis centers in the world managed by B. Braun.

B. Brown in Russia

Main article: V. Braun in Russia

History

2023

An employee of B. Braun admitted to forging documents for medical equipment - it was sold without the permission of regulators

On July 20, 2023, the US Department of Justice announced that Peter Stoll, a former employee of the German medical and pharmaceutical company B. Braun, pleaded guilty to falsifying documents. The man forged several permits on behalf of the Food and Drug Administration (FDA). Read more here.

Recall of defective infusion pumps after patient death

On November 17, 2023, the US Food and Drug Administration (FDA) announced that the medical and pharmaceutical company B. Braun Medical is recalling defective infusion pumps of the Infusomat Space family. The use of these devices can cause serious harm to the health of patients and provoke a fatal outcome. Read more here.

2022: Purchase from Starboard Medical of a business to produce catheter fixation devices

On September 27, 2022, B. Braun Medical announced the acquisition of a portfolio of fixation devices catheters Clik-FIX in. and Starboard Medical Financial other deal parameters are not disclosed. More. here

2015: Lauer takeover

In June 2015, it was announced that B. Braun Avitum AG acquired Lauer Membrane Wassertechnik GmbH, thereby supplementing its product range with dialysis water treatment systems. The Aquaboss system, manufactured by the Lauer family company, is one of the leading premium dialysis water treatment systems in the world, thanks to its innovative patented technology.

The partnership between Lauer and B. Braun in the dialysis market has been successful for many years. The acquisition of Lauer was B. Braun's response to increasing demand for dialysis products and services from a single source. With this acquisition, B. Braun intends to strengthen its market position in the future as a system provider in the field of dialysis therapy.

Lauer has been working in the field of water treatment for about 26 years. The Lauer plant, which is located in Wittlingen, Germany, employs 75 employees at this time. It was announced that the deal would not bring any significant changes for Lauer employees, as the company itself will continue to work as an autonomous division of the B. Braun group of companies. In addition to building up the dialysis products business, B. Brown Avitum AG is also significantly expanding the dialysis services provider business. As of 2015, nearly 24,000 patients are receiving dialysis therapy at 300 dialysis centers in the world managed by B. Braun.

2005: Buying Ascalon

In 2005 B. Braun acquires Ascalon Gesellscaft fur Innovation der Medizintechnologie GmbH and includes it in the medical technology division. Ascalon is a manufacturer of capillary membranes used to manufacture Saxonia Medical dialyzers.

2004: Takeover of Saxonia Medical

In 2004 B. Braun acquires Saxonia Medical GmbH and integrates it into the medical technology division. Saxonia Medical in Radeberg manufactures dialyzers and filters using state-of-the-art technology.

2001: Spin-off of B. Braun Melsungen AG into a separate company

In 2001, B. Braun Medizintechnologie GmbH is separated from the medical technology division and thus becomes 100% an enterprise of B. Braun Melsungen AG. Departments of extracorporeal treatment equipment, production of all consumables, research, sales, marketing, advertising, service, quality control, legal department - all of them are now part of this division.

2000: Sale of 90% stake in BBI to Sartorius

In 2000, B. Braun Melsungen AG ceded a 90% stake in BBI to Sartorius AG. The medical technology division remains a supplier of Sartorius BBI System GmbH.

1996: B. Braun becomes the most important manufacturer of dialysis solutions in Europe

In 1996, the medical technology division acquires Schiwa GmbH in Glandorf and Medizintechnik in Bremerhaven, which ensure the production of most dialysis solutions. This leads to an expansion of sales in Germany. The production of consumables is transferred to Glandorf. B. Braun is becoming the most important manufacturer of dialysis solutions in Europe.

1994: Restructuring

In 1994, B. Braun Melsungen AG is undergoing reconstitution. The Division of Extracorporeal Therapies is renamed the Medical Technology Division.

1987: Founding of BBI - Biotechnology Business

In 1986, an independent biotechnology department was founded. In 1987, the biotechnology group became an independent enterprise and is now called B. Braun Biotech International (BBI). Production remains at Melsungen.

1979: Merger of B. Braun FRABA with B. Braun Melsungen

1979: B. Braun FRABA GmbH moves its headquarters from Cologne to Melsungen. B. Braun FRABA GmbH merges with B. Braun Melsungen AG. In 1981, B. Braun FRABA joined the Medical and Laboratory Technology Department.

1969: Base B. Braun FRABA - Hemo- and Peritoneal Dialysis Machines

In 1969, B. Braun FRABA GmbH was founded in the city of Cologne. The company produces devices for hemo- and peritoneal dialysis, sells systems for blood transfusion. The name FRABA is derived from the name Franz Baumgartner - one of the pioneers and enthusiasts in the development of hemodialysis, who by this time was already producing dialysis machines. Franz Baumgartner was the first creator of an "artificial kidney" in the Federal Republic of Germany.

1960s: World's first sterile solutions for peritoneal dialysis in soft containers

In the 1960s, the Medical Device Development Department was the first in the world to start producing sterile solutions for peritoneal dialysis in soft containers.

1950: Establishment of the Medical Device Development Department

In 1950, the merger of glassblowing, mechanical workshop and plastic processing into the medical equipment development department laid the foundation for the future medical and laboratory business.

1919: The start of the production of medical equipment - tonometers and turnstiles

In 1919, manual production was supplemented by machine production and the workshop began to produce medical equipment - tonometers and turnstiles.

1914: Workshop for the manual manufacture of surgical brackets

At the beginning of World War I, B. Braun creates a workshop for the manual manufacture of surgical brackets.

1867: The name "B. Brown" is registered

Bernard Brown registered the name "B. Brown" on the commodity register. At that time, the company was divided into two divisions: Division A (pharmacy) and Division B (pharmaceutical products).

1864: Bernard Brown leads the venture. Launch of production of migraine patches and remedies

In 1864, the first production of pharmaceutical goods appeared. The management of the enterprise falls into the hands of Bernard Brown, the eldest son of Julius Wilhelm. It is launching the production of pharmaceutical products such as patches and migraine remedies.

1839: Wilhelm Brown buys "Rose" pharmacy

June 23, 1839 Julius Wilhelm Braun buys the Rosa pharmacy, an enterprise in the German city of Melsungen. The new owner expanded the activities of the pharmacy by introducing the function of postal delivery of local herbs.